Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001193125-25-324963

Options or other derivatives

  • Director acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Link David Director 2025-12-16 Grant or award · Stock Option (right to buy) +150,000 150,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…